Bristol-myers Squibb Compnay

Kishore V Renduchintala

Paul Michael Scola

Kandhasamy Sarkunam

Pulicharla Nagalakshmi

Li-Qiang Sun

Eric P Gillis

Qian Zhao

Nicholas A Meanwell

Eric Mull

Ramkumar Rajamani

Michael S Bowsher

William N Washburn

Pratik Devasthale

Sheldon Hiebert

Radhakrishnan Sridhar

Pvk Suresh Babu

P V K Suresh Babu

Suresh PVK Babu

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed. 

The present application provides compounds that are useful as MCHR1 antagonists, especially for the treatment of obesity, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I wherein the variables are defined herein.

Azolotriazinone melanin concentrating hormone receptor-1 antagonists

Growing community of inventors

Bengaluru, India

Kishore V Renduchintala